<b>Background/Objectives:</b> Hepatocellular carcinoma (HCC) exhibits enhanced glycolytic activity, primarily facilitated by Class I glucose transporters (GLUTs), particularly GLUT-2. Here, SLC2A2 is linked to hepatocellular carcinoma.